AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metarv 500mg Tablet

Prescription Icon
Prescription Required

Marketer

Arvantis Pharmaceuticals

Salt Composition

Metformin (500mg)

Overview Metarv 500mg Tablet

Diabex 500mg tablets are prescribed for managing type 2 diabetes mellitus, effectively regulating blood glucose and mitigating the risk of associated complications. This medication also addresses Polycystic Ovary Syndrome (PCOS) in women. For optimal absorption and to minimize gastrointestinal upset, Diabex 500mg should be taken with food, consistently at the same time daily. Discontinuation should only occur under medical supervision. Maintaining a healthy lifestyle is crucial for diabetes control; therefore, adherence to the physician's dietary and exercise plan is essential during treatment. Commonly reported adverse effects include nausea, vomiting, diarrhea, abdominal discomfort, flatulence, headache, weakness, and decreased appetite. Concurrent use with other antidiabetic medications, alcohol consumption, or missed meals may result in hypoglycemia (low blood sugar). Regular blood glucose monitoring is vital. Prior to commencing treatment, patients with pre-existing kidney, liver, or heart conditions, as well as pregnant or breastfeeding individuals, should seek medical counsel. Kidney function assessment will be performed before prescription. Excessive alcohol consumption should be avoided due to a heightened risk of side effects.

Primary Ingredients of Metarv 500mg Tablet

No text provided to rephrase.

Uses of Metarv 500mg Tablet

Management of type 2 diabetes and polycystic ovary syndrome

Major Benefits of Metarv 500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the 500mg Metarv tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

Common Side effects of Metarv 500mg Tablet:

  • Diarrhea
  • Headache
  • Vomiting
  • Nausea
  • Flatulence
  • Abdominal discomfort
  • Weakness

How to use Metarv 500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 500mg Metarv tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with food.

How Metarv 500mg Tablet works:

Glucovance 500mg tablets, a biguanide class antidiabetic agent, reduces hepatic glucose output, slows intestinal glucose uptake, and enhances insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Metarv 500mg tablets is unsafe.

PregnancyPregnancySAFE IF PRESCRIBED

The use of Metarv 500mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or absent harm to offspring; nevertheless, data from human trials are scarce.

Breast feedingBreast feedingCAUTION

Administering Metarv 500mg Tablets to breastfeeding mothers requires careful consideration. Breastfeeding should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.

DrivingDrivingCAUTION

Impaired driving is possible with excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Exercise caution when administering Metarv 500mg Tablets to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is advised. Metarv 500mg Tablets are contraindicated in patients exhibiting severe kidney disease.

LiverLiverUNSAFE

Individuals with hepatic impairment should likely refrain from using Metarv 500mg tablets due to potential safety concerns. A physician's consultation is advised.

What if you forget to take Metarv 500mg Tablet :

Should you forget a Metarv 500mg Tablet dose, administer it promptly. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metarv 500mg Tablet

LabelValue
Pharmaceutical Classification Biguanide-based medication
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Metarv 500mg Tablet

Individuals with type 2 diabetes exhibit impaired responsiveness to their body's insulin production. This results in elevated blood glucose concentrations. Metarv 500mg Tablet employs multiple mechanisms to lower these heightened sugar levels. It reduces hepatic glucose production, diminishes intestinal glucose absorption postprandially, and enhances insulin sensitivity in tissues. Consequently, glucose uptake from the bloodstream is improved, and the body's natural insulin response is augmented.
Metarv 500mg tablets have demonstrated weight reduction in overweight and obese patients. A slight weight decrease has also been observed in overweight and obese individuals predisposed to diabetes. Furthermore, weight loss may occur in insulin-resistant or insulin-sensitive patients. However, self-initiation of Metarv 500mg tablets for weight management is inadvisable; physician consultation is required.
Metarv 500mg tablets are frequently an initial treatment for hyperglycemia. This medication manages blood glucose by enhancing insulin responsiveness, reducing hepatic glucose production, and limiting intestinal glucose absorption. In contrast to other oral hypoglycemics, Metarv 500mg tablets, when used as monotherapy, infrequently induce hypoglycemia due to their mechanism of preventing excessive insulin release. Beyond glycemic control, this medication also aids in weight management.
Metarv 500mg tablets generally do not induce drowsiness and are typically well-received. Infrequently, however, Metarv 500mg tablets may lead to sleep disturbances and insomnia. Somnolence can be a symptom of a severe adverse reaction known as lactic acidosis, especially prevalent in individuals with impaired kidney function. Consult your physician if fatigue or sleepiness develops during Metarv 500mg tablet use.
Administer Metarv 500mg tablets with or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily prescriptions, consume with breakfast. Twice-daily regimens should involve one tablet in the morning and one in the evening with dinner. Three times daily, distribute doses with breakfast, lunch, and dinner. Ingesting Metarv 500mg tablets with food mitigates potential gastrointestinal distress, including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to their endogenous insulin. This results in elevated blood glucose concentrations. Metarv 500mg Tablet employs a multifaceted approach to lower these elevated blood sugar levels. It reduces hepatic glucose production, diminishes intestinal glucose absorption postprandially, and enhances insulin sensitivity in bodily tissues. This combined action facilitates improved glucose uptake from the bloodstream and augments the body's natural insulin response.
Individuals overweight or obese have experienced weight reduction while taking Metarv 500mg Tablets. This weight loss effect may also be observed in overweight or obese patients predisposed to diabetes. Furthermore, those with insulin sensitivity or resistance might also lose weight. However, self-medicating with Metarv for weight management is strongly discouraged; physician consultation is mandatory before initiating treatment.
Metarv 500mg tablets are among the initial treatments prescribed for hyperglycemia. This medication regulates blood glucose by enhancing the body's insulin responsiveness, reducing hepatic glucose production, and diminishing intestinal glucose absorption. Unlike other oral hypoglycemics, Metarv 500mg tablets, when used monotherapy, infrequently induce hypoglycemia due to their inhibition of excessive pancreatic insulin release. Beyond its glycemic control benefits, this medication also aids in weight management.
Metarv 500mg tablets generally don't induce drowsiness and are usually well-received. Infrequently, though, Metarv 500mg tablets might lead to sleep disturbances or insomnia. Drowsiness can be a symptom of a severe adverse reaction known as lactic acidosis, especially prevalent in individuals with impaired kidney function. Consult your physician if fatigue or sleepiness develops during Metarv 500mg tablet use.
Administer Metarv 500mg tablets with or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily regimens, morning administration with breakfast is recommended. Twice-daily prescriptions should be divided into morning and evening doses, taken with breakfast and dinner respectively. Three times daily, distribute doses with breakfast, lunch, and dinner. Consuming Metarv 500mg with food mitigates potential gastrointestinal distress, including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to their own insulin. This results in elevated blood glucose levels. Metarv 500mg Tablet employs multiple mechanisms to lower these high blood sugar levels. It reduces hepatic glucose production, diminishes intestinal glucose absorption following meals, and enhances insulin sensitivity in tissues and organs. This facilitates improved glucose uptake from the bloodstream. Furthermore, it promotes a more effective response to naturally produced insulin.
Individuals overweight or obese have experienced weight reduction while using Metarv 500mg tablets. This weight loss effect may also be observed in overweight or obese individuals predisposed to diabetes. Furthermore, patients with insulin sensitivity or resistance might also lose weight. However, self-prescribing Metarv for weight management is inadvisable; physician consultation is essential.
Metarv 500mg tablets are among the initial treatments prescribed for hyperglycemia. This medication regulates blood glucose by enhancing the body's insulin response, reducing hepatic glucose production, and limiting intestinal sugar absorption. Differing from other oral hypoglycemics, Metarv 500mg tablets, when used independently, infrequently induce hypoglycemia due to their inhibition of excessive insulin secretion. Beyond glycemic control, this medication also aids in managing weight increase.
Metarv 500mg tablets generally do not induce drowsiness and are typically well-received. Infrequently, however, Metarv 500mg tablets may lead to sleep disturbances or insomnia. Somnolence can be a symptom of a severe adverse reaction known as lactic acidosis, especially if renal function is impaired. Consult your physician if fatigue or sleepiness develops during Metarv 500mg tablet use.
Administer Metarv 500mg tablets with or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily prescriptions, morning ingestion with breakfast is recommended. For twice-daily regimens, divide doses between morning and evening meals. Three times daily, distribute doses with breakfast, lunch, and dinner. Consuming Metarv 500mg tablets with food mitigates potential gastrointestinal distress, such as indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Metarv 500mg Tablet
32
MRP 37
14% off